Registra tu Blog
( What is this? )
I Home I More views Today I xxx I xxx I xxx I xxx I xxx I Registra tu Blog I
 

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

-
Noticias destacadas
Fuente: Noticias de Salud - Ver todas las noticias de este sitio
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis






 Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisEdurne Arriola 1, Mara Gonzlez-Cao 2, Manuel Domine 3, Javier De Castro 4, Manuel Cobo 5, Reyes Bernab 6, Alejandro Navarro 7, Ivana Sullivan 8, Jos Manuel Trigo 9, Joaqun Mosquera 10, Leonardo Crama 11, Dolores Isla 12Affiliations expandPMID: 35032007 DOI: 10.1007/s40487-021-00182-0AbstractIntroduction: The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment improves survival in extensive-stage small-cell lung cancer (ES-SCLC). The aim of this meta-analysis was to determine the relative efficacy of first-line ICIs compared with CT in patients with ES-SCLC.Methods: Two independent reviewers extracted relevant data according to PRISMA guidelines and assessed the risk of bias using the Cochrane Collaboration's risk-of-bias tool. Meta-analysis was conducted using random-effects models to calculate an average effect size for overall survival (OS), progression-free survival (PFS), and safety outcomes in the overall populations and clinically relevant subgroups.Results: A literature search of PubMed and Embase was performed. Six randomized controlled clinical trials (IMpower133, CHECKMA...
articulo visto
0
veces, esta semana
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

facebook:
twitter:

Fuente de la noticia: Noticias de Salud
Fuente de la publicacion: 12-05-2022 16:05
visto: 0

Si te gusto esta noticia puede que te interesen estas..

------------------------------------------------------------------------------------------------------------
Recommended Video section of our Noticias destacadas - Watch More Videos in Noticias destacadas

Go TO TV Noticias destacadas

Si te gusto esta noticia puede que te interesen estas..

 

 



Quieres que tu blog y articulos salgan aqui?


 
         

Categorias

Blogs mas vistos los ultimos 7 dias

Noticias mas vistas hoy


Ver mas Blogs
Social
 

RSSarticle Directory
- Insert Blog

 

Contacto:
[email protected]